Next Article in Journal
Molecular and Clinical Characteristics of Different Toxicity Rates in Anti-CD19 Chimeric Antigen Receptor T Cells: Real-World Experience
Next Article in Special Issue
Resistance of Lung Cancer to EGFR-Specific Kinase Inhibitors: Activation of Bypass Pathways and Endogenous Mutators
Previous Article in Journal
Interdisciplinary Therapeutic Approaches to Atypical and Malignant Meningiomas
Previous Article in Special Issue
Large, Nested Variant of Urothelial Carcinoma Is Enriched with Activating Mutations in Fibroblast Growth Factor Receptor-3 among Other Targetable Mutations
 
 
Article

Article Versions Notes

Cancers 2023, 15(17), 4252; https://doi.org/10.3390/cancers15174252
Action Date Notes Link
article xml file uploaded 25 August 2023 08:19 CEST Original file -
article xml uploaded. 25 August 2023 08:19 CEST Update -
article pdf uploaded. 25 August 2023 08:19 CEST Version of Record https://www.mdpi.com/2072-6694/15/17/4252/pdf-vor
article supplementary file uploaded. 25 August 2023 08:19 CEST - https://www.mdpi.com/2072-6694/15/17/4252#supplementary
article xml file uploaded 25 August 2023 08:20 CEST Update -
article xml uploaded. 25 August 2023 08:21 CEST Update -
article pdf uploaded. 25 August 2023 08:21 CEST Updated version of record https://www.mdpi.com/2072-6694/15/17/4252/pdf-vor
article html file updated 25 August 2023 08:22 CEST Original file -
article xml file uploaded 28 August 2023 08:30 CEST Update -
article xml uploaded. 28 August 2023 08:31 CEST Update -
article pdf uploaded. 28 August 2023 08:31 CEST Updated version of record https://www.mdpi.com/2072-6694/15/17/4252/pdf
article html file updated 28 August 2023 08:33 CEST Update -
article xml uploaded. 20 September 2023 10:26 CEST Update https://www.mdpi.com/2072-6694/15/17/4252/xml
article html file updated 20 September 2023 10:28 CEST Update https://www.mdpi.com/2072-6694/15/17/4252/html
Back to TopTop